(3S,6S,9S,12S,18S,21S,24S,27S,30R,34S)-6,27-dibenzyl-24-[(5-fluoro-3-pyridinyl)methoxymethyl]-18-[(1R)-1-hydroxyethyl]-4,7,13,16,22,28-hexamethyl-9-[(2-methylpropan-2-yl)oxymethyl]-12,21-bis(2-methylpropyl)-34-(piperidine-1-carbonyl)-3,30-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotetratriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
C77H116FN13O15 — CID 153487211
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3S,6S,9S,12S,18S,21S,24S,27S,30R,34S)-6,27-dibenzyl-24-[(5-fluoro-3-pyridinyl)methoxymethyl]-18-[(1R)-1-hydroxyethyl]-4,7,13,16,22,28-hexamethyl-9-[(2-methylpropan-2-yl)oxymethyl]-12,21-bis(2-methylpropyl)-34-(piperidine-1-carbonyl)-3,30-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotetratriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
(3S,6S,9S,12S,18S,21S,24S,27S,30R,34S)-6,27-dibenzyl-24-[(5-fluoro-3-pyridinyl)methoxymethyl]-18-[(1R)-1-hydroxyethyl]-4,7,13,16,22,28-hexamethyl-9-[(2-methylpropan-2-yl)oxymethyl]-12,21-bis(2-methylpropyl)-34-(piperidine-1-carbonyl)-3,30-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotetratriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone (PubChem CID 153487211) has the molecular formula C77H116FN13O15 and a molecular weight of 1482.85 g/mol. Its IUPAC name is (3S,6S,9S,12S,18S,21S,24S,27S,30R,34S)-6,27-dibenzyl-24-[(5-fluoro-3-pyridinyl)methoxymethyl]-18-[(1R)-1-hydroxyethyl]-4,7,13,16,22,28-hexamethyl-9-[(2-methylpropan-2-yl)oxymethyl]-12,21-bis(2-methylpropyl)-34-(piperidine-1-carbonyl)-3,30-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotetratriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone.
Molecular Properties
| Compound Name | (3S,6S,9S,12S,18S,21S,24S,27S,30R,34S)-6,27-dibenzyl-24-[(5-fluoro-3-pyridinyl)methoxymethyl]-18-[(1R)-1-hydroxyethyl]-4,7,13,16,22,28-hexamethyl-9-[(2-methylpropan-2-yl)oxymethyl]-12,21-bis(2-methylpropyl)-34-(piperidine-1-carbonyl)-3,30-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotetratriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone |
|---|---|
| PubChem CID | 153487211 |
| Molecular Formula | C77H116FN13O15 |
| Molecular Weight | 1482.85 g/mol |
| Exact Mass | 1481.87 |
| IUPAC Name | (3S,6S,9S,12S,18S,21S,24S,27S,30R,34S)-6,27-dibenzyl-24-[(5-fluoro-3-pyridinyl)methoxymethyl]-18-[(1R)-1-hydroxyethyl]-4,7,13,16,22,28-hexamethyl-9-[(2-methylpropan-2-yl)oxymethyl]-12,21-bis(2-methylpropyl)-34-(piperidine-1-carbonyl)-3,30-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotetratriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone |
| SMILES | CC(C)C[C@H]1C(=O)N[C@@H](COC(C)(C)C)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)N(C)[C@@H](C(C)C)C(=O)N[C@H](C(=O)N2CCCCC2)CC(=O)N[C@H](C(C)C)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)N[C@@H](COCc2cncc(F)c2)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N(C)CC(=O)N1C |
| InChI | InChI=1S/C77H116FN13O15/c1-46(2)34-58-67(95)82-57(45-106-77(10,11)12)72(100)89(17)61(38-52-30-24-20-25-31-52)74(102)90(18)66(49(7)8)70(98)80-55(73(101)91-32-26-21-27-33-91)39-62(93)83-64(48(5)6)76(104)88(16)60(37-51-28-22-19-23-29-51)68(96)81-56(44-105-43-53-36-54(78)41-79-40-53)71(99)87(15)59(35-47(3)4)69(97)84-65(50(9)92)75(103)85(13)42-63(94)86(58)14/h19-20,22-25,28-31,36,40-41,46-50,55-61,64-66,92H,21,26-27,32-35,37-39,42-45H2,1-18H3,(H,80,98)(H,81,96)(H,82,95)(H,83,93)(H,84,97)/t50-,55+,56+,57+,58+,59+,60+,61+,64-,65+,66+/m1/s1 |
| InChIKey | JURSKLVUENPRKE-MYNZXKBOSA-N |
| XLogP | 3.26 |
| TPSA | 339.25 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 18 |
| Heavy Atoms | 106 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1482.85 |
| LogP ≤ 5 | 3.26 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 16 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 153487211 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.